NCT01669967View on ClinicalTrials.gov

The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Neuropathic Pain
Interventions
DRUG

Lidocaine

Lidocaine 5 mg/kg in 250 ml of normal saline infused over 45 minutes.

DRUG

Diphenhydramine

Diphenhydramine 50 mg in 250 ml of normal saline infused over 45 minutes.

Trial Locations (1)

N6A 4V2

St. Joseph's Health Care, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT01669967 - The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin | Biotech Hunter | Biotech Hunter